UNDERREPRESENTATION OF WOMEN IN CLINICAL DRUG TRIALS

被引:31
作者
SCHMUCKER, DL
VESELL, ES
机构
[1] PENN STATE UNIV,MILTON S HERSHEY MED CTR,COLL MED,DEPT PHARMACOL,HERSHEY,PA 17033
[2] UNIV CALIF SAN FRANCISCO,DEPT ANAT,SAN FRANCISCO,CA 94143
[3] UNIV CALIF SAN FRANCISCO,CTR LIVER,SAN FRANCISCO,CA 94143
关键词
D O I
10.1038/clpt.1993.102
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Clinical Pharmacology and Therapeutics (1993) 54, 11–15; doi: © 1993 American Society for Clinical Pharmacology and Therapeutics
引用
收藏
页码:11 / 15
页数:5
相关论文
共 9 条
[1]   UNDERREPRESENTATION OF WOMEN IN NEW DRUG TRIALS - RAMIFICATIONS AND REMEDIES [J].
KINNEY, EL ;
TRAUTMANN, J ;
GOLD, JA ;
VESELL, ES ;
ZELIS, R .
ANNALS OF INTERNAL MEDICINE, 1981, 95 (04) :495-499
[2]   RESEARCH ON WOMENS HEALTH [J].
KIRSCHSTEIN, RL .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1991, 81 (03) :291-293
[3]   BRIDGING THE GENDER-GAP IN RESEARCH [J].
LEVEY, BA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (06) :641-646
[4]   WHY ARE TOXIC REACTIONS TO DRUGS SO OFTEN UNDETECTED INITIALLY [J].
VESELL, ES .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (18) :1027-1029
[5]  
1990, NIYH GUIDE GRANTS CO, V19, P18
[6]  
1991, BLUE SHEET, V34, P3
[7]  
1992, PHYSICIANS DESK REFE
[8]  
1992, BLUE SHEET, V93, P17
[9]  
1990, NIH GAOTHRD9038 GEN